Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Trane Technologies (TT) Q4 Earnings Beat Estimates, Up Y/Y

Published 01/31/2022, 01:18 AM
Updated 07/09/2023, 06:31 AM

Trane Technologies (NYSE:TT) plc TT reported better-than-expected fourth-quarter 2021 results.

Adjusted EPS of $1.36 surpassed the Zacks Consensus Estimate by 3.8% and increased 32% year over year. Revenues of $3.6 billion topped the consensus mark by 1.1% and increased 12% year over year on a reported basis and 11% organically. Bookings were up 28% year over year on a reported basis and 27% organically, to $4.1 billion.

The company’s shares have gained 20.6% over the past year against 60% decline of the industry it belongs to.

Revenues and Bookings Up in all Segments

The Americas segment’s revenues of $2.7 billion increased 15% year over year on a reported basis and 14% on an organic basis. Bookings grew 33% on a reported basis and 31% organically, to $3.2 billion.

Europe, Middle East and Africa (EMEA) segment’s revenues came in at $482.8 million, up 4% year over year on a reported basis and 5% organically. Bookings were up 12% on a reported basis and 13% organically, to $510.3 million.

Revenues from the Asia Pacific segment were up 3% year over year on a reported basis and 4% on an organic basis, to $337 million. Bookings of $377.1 million increased 18% on a reported basis as well as organically.

Strong Margin Performance

Adjusted EBITDA came in at $525 million, up 14% year over year. Adjusted EBITDA margin improved 30 basis points (bps) to 14.7%. Adjusted operating income of $447 million increased 13% year over year with adjusted operating margin improving10 bps to 12.5%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Key Balance Sheet and Cash Flow Figures

Trane ended the quarter with cash balance of $2.2 billion compared with $2.7 billion at the end of the previous quarter. Debt balance was $4.8 billion, flat with the previous quarter's figure.

The company generated $1.6 billion of cash from operating activities in 2021 while capital expenditures were $163 million. Free cash flow was $1.4 billion.

2022 Guidance

Adjusted EPS is expected to be between $6.95 to $7.15, up 14% to 17% year over year. The midpoint ($7.05) of the guided range is above the current Zacks Consensus Estimate of $7.

Trane currently carries a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Some Other Business Services Companies

Automatic Data Processing (NASDAQ:ADP) ADP reported better-than-expected second-quarter fiscal 2022 results. Adjusted EPS of $1.65 beat the Zacks Consensus Estimate by 1.2% and rose 9% year over year.

Total revenues of $4.03 billion beat the consensus mark by 1.1% and increased 9% year over year. ADP currently carries a Zacks Rank #2 (Buy).

Robert Half International RHI delivered fourth-quarter 2021 earnings of $1.51 per share that beat the consensus mark by 5.6% and rose 79.8% year over year.

Revenues of $1.77 billion surpassed the consensus mark by 4.3% and increased 36.2% year over year on a reported basis and 36% on an as-adjusted basis. RHI currently carries a Zacks Rank #2.

Rollins (NYSE:ROL) ROL reported mixed fourth-quarter 2021 results, with earnings meeting the Zacks Consensus Estimate and revenues beating the same. Adjusted earnings of 14 cents per share meet the Zacks Consensus Estimate and increased 7.7% year over year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Revenues of $600.3 million beat the consensus mark by 3.3% and rose 11.9% year over year. ROL currently carries a Zacks Rank #2.


Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer (NYSE:SAM) Company which shot up +143.0% in little more than 9 months and NVIDIA (NASDAQ:NVDA) which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Automatic Data Processing, Inc. (ADP): Free Stock Analysis Report

Robert Half International Inc. (NYSE:RHI): Free Stock Analysis Report

Rollins, Inc. (ROL): Free Stock Analysis Report

Trane Technologies plc (TT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.